OICR, Intensity Therapeutics and The Ottawa Hospital to conduct Window of Opportunity clinical trial in early-stage breast cancer

Combination of erectile dysfunction drugs and flu vaccine may help kill remaining cancer after surgery

Scientists create method to sensitize triple-negative breast cancer to common immunotherapy

CCRC brings Canadian cancer researchers together

Ontario start-up makes major deal to develop cancer-fighting viruses

How OICR is helping to boost the body’s ability to fight cancer

Study bringing more precision medicine to Ontario’s cancer patients

Clinical trial opens for promising combination therapy

FACIT start-up Turnstone Biologics closes USD $41M financing

OICR funds world-first clinical trial using cancer-fighting viruses

FACIT start-up company Turnstone Biologics secures $11.3 million in financing, boosts leadership

Cancer patients treated in world-first clinical trial of Canadian viral therapy